Skip to main content
Log in

Bowel obstruction in home-care cancer patients: 4 years experience

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Conservative management of bowel obstruction in advanced cancer patients has been recognized as efficacious in controlling distressing symptoms such as nausea, vomiting and pain. A retrospective analysis of prevalence, treatment and outcome was performed. A group of 25 patients with signs of bowel obstruction were studied from 1001 consecutive patients receiving palliative care at home. A score for total distress was calculated to assess the gastrointestinal symptoms at diagnosis, after 1 week of treatment and 1 day before death. The mean survival was 19 days. Six patients were admitted to hospital, 3 of whom underwent surgery and died in the immediate postoperative period. The patients diagnosed in hospital and discharged received a nasogastric tube (7 cases) and a central venous line. The nasogastric tube was removed after gastrointestinal secretions had been controlled by a combination of drugs, and parenteral nutrition or hydration, mainly started in hospital, was discontinued only a few days before death (13 cases, mean duration 19 days). The distress symptom score was statistically reduced after 1 week of treatment and on the day before death when compared to the referral time. The most frequent combination of drugs was octreotide, haloperidol and low doses of morphine. A subcutaneous route was preferred for administering the drugs. Utilization of a wide range of drugs permits good symptom control for bowel obstruction in patients followed at home.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Allan SG (1993) Nausea and vomiting. In: Doyle D, Hanks GW, MacDonald N (eds) Oxford text book of palliative medicine. Oxford Medical Publications, Oxford, pp 282–290

    Google Scholar 

  2. Baines MJ (1993) The pathophysiology and management of malignant intestinal obstruction. In: Doyle D, Hanks GW, MacDonald N (eds) Oxford text book of palliative medicine. Oxford Medical Publications, Oxford, pp 311–315

    Google Scholar 

  3. Baines M, Oliver DJ, Carter RL (1985) Medical management of intestinal obstruction in patients with advanced malignant disease. Lancet II:990–993

    Google Scholar 

  4. Bruera E, MacDonald RN (1989) Nutrition in patients with advanced cancer: an update and review of our experience. J Pain Symptom Manage 3:133–140

    Google Scholar 

  5. Chan A, Woodruff RK (1992) Intestinal obstruction in patients with wide-spread intraabdominal malignancy. J Pain Symptom Manage 7:339–342

    Google Scholar 

  6. De Conno F, Caraceni A, Zecca E, Spoldi E, Ventafridda V (1991) Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 6:484–486

    Google Scholar 

  7. Fainsinger R, Chan K, Bruera E (1992) Total parenteral nutrition for a terminally ill patients? J Palliat Care 8:30–32

    Google Scholar 

  8. Fainsinger R, Spachynski K, Hanson J, Bruera E (1994) Symptom control in terminally ill patients with malignant bowel obstruction. J Pain Symptom Manage 9:12–18

    Google Scholar 

  9. Isbister WH, Elder P, Symons L (1990) Non-operative management of malignant intestinal obstruction. J R Coll Surg Edinb 35:369–372

    Google Scholar 

  10. Khoo D, Hall E, Motson R, Riley J, Deman K, Waxman J (1994) Palliation of malignant obstruction using octreotide. Eur J Cancer 30:28–30

    Google Scholar 

  11. Mercadante S (1994) I sintomi gastrointestinali. In: Mercadante S (ed) Trattamento del dolore e dei sintomi nel cancro avanzato. Piccin, Padova, pp 135–151

    Google Scholar 

  12. Mercadante S (1994) Parenteral nutrition at home in advanced cancer patients. J Pain Symptom Manage (in press)

  13. Mercadante S (1994) The role of octreotide in palliative care. J Pain Symptom Manage (in press)

  14. Mercadante S, Genovese G, Kargar JA, Maddaloni S, Roccella S, Salvaggio L, Simonetti MT (1992) Home palliative care: results in 1991 versus 1988. J Pain Symptom Manage 7:414–418

    Google Scholar 

  15. Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MT (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7:295–299

    Google Scholar 

  16. Riley J, Fallon MT (1994) Octreotide in terminal malignant obstruction of the gastrointestinal tract. Eur J Palliat Care 1:2325

    Google Scholar 

  17. Ripamonti C, De Conno F, Ventafridda V, Rossi B, Baines MJ (1993) Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol 4:15–21

    Google Scholar 

  18. Ventafridda V, Ripamonti C, Caraceni A, Spoldi E, Messina L, De Conno F (1990) The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76:389–393

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mercadante, S. Bowel obstruction in home-care cancer patients: 4 years experience. Support Care Cancer 3, 190–193 (1995). https://doi.org/10.1007/BF00368889

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00368889

Key words

Navigation